234 related articles for article (PubMed ID: 22229564)
1. Phenotypes and enviromental factors: their influence in PCOS.
Diamanti-Kandarakis E; Christakou C; Marinakis E
Curr Pharm Des; 2012; 18(3):270-82. PubMed ID: 22229564
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome and environmental toxins.
Rutkowska AZ; Diamanti-Kandarakis E
Fertil Steril; 2016 Sep; 106(4):948-58. PubMed ID: 27559705
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs).
Palioura E; Diamanti-Kandarakis E
Rev Endocr Metab Disord; 2015 Dec; 16(4):365-71. PubMed ID: 26825073
[TBL] [Abstract][Full Text] [Related]
4. Industrial endocrine disruptors and polycystic ovary syndrome.
Palioura E; Diamanti-Kandarakis E
J Endocrinol Invest; 2013 Dec; 36(11):1105-11. PubMed ID: 24445124
[TBL] [Abstract][Full Text] [Related]
5. Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects.
Palioura E; Kandaraki E; Diamanti-Kandarakis E
Horm Mol Biol Clin Investig; 2014 Mar; 17(3):137-44. PubMed ID: 25372737
[TBL] [Abstract][Full Text] [Related]
6. Bisphenol A and polycystic ovary syndrome in human: A systematic review.
Urbanetz LAML; Soares-Junior JM; Dos Santos Simões R; Maciel GAR; Baracat MCP; Baracat EC
Int J Gynaecol Obstet; 2024 Jul; 166(1):190-203. PubMed ID: 38197560
[TBL] [Abstract][Full Text] [Related]
7. Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS).
Rutkowska A; Rachoń D
Gynecol Endocrinol; 2014 Apr; 30(4):260-5. PubMed ID: 24397396
[TBL] [Abstract][Full Text] [Related]
8. Bisphenol-A and polycystic ovary syndrome: a review of the literature.
Kechagias KS; Semertzidou A; Athanasiou A; Paraskevaidi M; Kyrgiou M
Rev Environ Health; 2020 Nov; 35(4):323-331. PubMed ID: 32663175
[TBL] [Abstract][Full Text] [Related]
9. Does bisphenol A (BPA) participates in the pathogenesis of Polycystic Ovary Syndrome (PCOS)?
Urbanetz LAML; Junior JMS; Maciel GAR; Simões RDS; Baracat MCP; Baracat EC
Clinics (Sao Paulo); 2023; 78():100310. PubMed ID: 38008036
[TBL] [Abstract][Full Text] [Related]
10. Do Advanced Glycation End Products (AGEs) Contribute to the Comorbidities of Polycystic Ovary Syndrome (PCOS)?
Rutkowska AZ; Diamanti-Kandarakis E
Curr Pharm Des; 2016; 22(36):5558-5571. PubMed ID: 27412301
[TBL] [Abstract][Full Text] [Related]
11. Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?
Garg D; Merhi Z
Nutrients; 2015 Dec; 7(12):10129-44. PubMed ID: 26690206
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products and their relevance in female reproduction.
Merhi Z
Hum Reprod; 2014 Jan; 29(1):135-45. PubMed ID: 24173721
[TBL] [Abstract][Full Text] [Related]
13. The impact of obesity on reproduction in women with polycystic ovary syndrome.
Pasquali R; Gambineri A; Pagotto U
BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
[TBL] [Abstract][Full Text] [Related]
14. Endocrine disruptors and polycystic ovary syndrome (PCOS): elevated serum levels of bisphenol A in women with PCOS.
Kandaraki E; Chatzigeorgiou A; Livadas S; Palioura E; Economou F; Koutsilieris M; Palimeri S; Panidis D; Diamanti-Kandarakis E
J Clin Endocrinol Metab; 2011 Mar; 96(3):E480-4. PubMed ID: 21193545
[TBL] [Abstract][Full Text] [Related]
15. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between advanced glycation end products and vitamin D: A compelling paradigm for the treatment of ovarian dysfunction in PCOS.
Merhi Z
Mol Cell Endocrinol; 2019 Jan; 479():20-26. PubMed ID: 30170183
[TBL] [Abstract][Full Text] [Related]
17. The obesogen tributyltin induces features of polycystic ovary syndrome (PCOS): a review.
Merlo E; Silva IV; Cardoso RC; Graceli JB
J Toxicol Environ Health B Crit Rev; 2018; 21(3):181-206. PubMed ID: 30015594
[TBL] [Abstract][Full Text] [Related]
18. Obesity and the polycystic ovary syndrome.
Gambineri A; Pelusi C; Vicennati V; Pagotto U; Pasquali R
Int J Obes Relat Metab Disord; 2002 Jul; 26(7):883-96. PubMed ID: 12080440
[TBL] [Abstract][Full Text] [Related]
19. Polycystic ovary syndrome: the influence of environmental and genetic factors.
Diamanti-Kandarakis E; Piperi C; Spina J; Argyrakopoulou G; Papanastasiou L; Bergiele A; Panidis D
Hormones (Athens); 2006; 5(1):17-34. PubMed ID: 16728382
[TBL] [Abstract][Full Text] [Related]
20. Serum bisphenol A concentrations correlate with serum testosterone levels in women with polycystic ovary syndrome.
Konieczna A; Rachoń D; Owczarek K; Kubica P; Kowalewska A; Kudłak B; Wasik A; Namieśnik J
Reprod Toxicol; 2018 Dec; 82():32-37. PubMed ID: 30266220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
